Markets:

Overview

News

Currencies

International

Treasuries

ProQR Therapeutics N.V. - Ordinary Shares (NQ:PRQR)

1.820 +0.100 (+5.81%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ProQR Therapeutics N.V. - Ordinary Shares

< Previous 1 2 3 4 5 Next >

Recap: ProQR Therapeutics Q1 Earnings ↗

May 16, 2023

Via Benzinga

ProQR Announces First Quarter 2023 Operating and Financial Results

May 16, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023

May 09, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

ProQR Announces Upcoming Investor Conferences in April and May

April 20, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

Earnings Outlook For ProQR Therapeutics ↗

March 28, 2023

Via Benzinga

ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023

April 18, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗

March 30, 2023

Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S....

Via Benzinga

S&P 500 Up 1%; Bluebird Bio Shares Plummet ↗

March 29, 2023

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also...

Via Benzinga

Why Shares of ProQR Therapeutics Dropped on Wednesday ↗

March 29, 2023

The clinical-stage biotech released fourth-quarter and full-year earnings.

Via The Motley Fool

Nasdaq Rises 1%; US Pending Home Sales Increase In February ↗

March 29, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P...

Via Benzinga

Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.

Via Benzinga

US Stocks Open Higher, Dow Jumps Over 200 Points ↗

March 29, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%...

Via Benzinga

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

March 29, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing

March 14, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

ProQR to Present at Upcoming Scientific and Industry Conferences

March 07, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023

February 28, 2023

From ProQR Therapeutics N.V.

Via GlobeNewswire

Tesla To $175? Here Are 10 Other Price Target Changes For Friday ↗

December 23, 2022

Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market...

Via Benzinga

Dow Dips 600 Points; AMC Entertainment Shares Plunge ↗

December 22, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday.

Via Benzinga

SKLZ Stock Alert: Will Skillz Shares Get Delisted? ↗

December 22, 2022

Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange.

Via InvestorPlace

Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today? ↗

December 22, 2022

Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday!

Via InvestorPlace

Why Is ProQR (PRQR) Stock Up 83% Today? ↗

December 22, 2022

ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY).

Via InvestorPlace

Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗

December 22, 2022

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher ↗

December 22, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.

Via Benzinga

Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3 ↗

December 22, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.

Via Benzinga

ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration ↗

December 22, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 22, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday!

Via InvestorPlace

ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

December 22, 2022

From ProQR Therapeutics N.V.

Via GlobeNewswire

Lilly and ProQR to Expand RNA Editing Collaboration

December 22, 2022

New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology

From ProQR Therapeutics N.V.

Via GlobeNewswire

ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022

November 14, 2022

From ProQR Therapeutics N.V.

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.